secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcadia Biosciences, Inc. (RKDA)
CIK:        0001469443
Form:       8-K
Filed at:   2022-09-27T23:59:59+00:00
Accession:  0000950170-22-018903
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Arcadia Biosciences gets Nasdaq delisting notice for bid price below $1.00
--------------------------------------------------------------------------

- Nasdaq notified Arcadia on Sept 27 that common stock failed minimum $1.00 bid price for 30 consecutive days.
- Company has 180 calendar days, until March 27, 2023, to regain compliance; stock continues trading on Nasdaq Capital Market.
- To cure, closing bid price must be at least $1.00 for ten consecutive business days during the grace period.
- If not compliant by March 2023, may qualify for second 180-day period if it meets other listing standards and plans reverse stock split.
- Arcadia is monitoring bid price and may consider options, including a reverse stock split, to regain compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1469443/000095017022018903/0000950170-22-018903-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1469443/000095017022018903/rkda-20220927.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-018903

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer